FDA Inspection 1022216 — Sergey V. Orlov
The FDA completed an inspection of Sergey V. Orlov on Mar 24, 2017 in Saint Petersburg, 197022. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Petersburg, 197022 (Russia)
Additional Details
Clinical Investigator (CI)